45 results
424B2
AQST
Aquestive Therapeutics Inc
24 Apr 24
Prospectus for primary offering
6:25am
and (c) similar to emerging growth companies, we are subject to reduced disclosure obligations regarding executive compensation arrangements in our
424B2
AQST
Aquestive Therapeutics Inc
24 Apr 24
Prospectus for primary offering
6:23am
and (c) similar to emerging growth companies, we are subject to reduced disclosure obligations regarding executive compensation arrangements in our
424B5
AQST
Aquestive Therapeutics Inc
21 Mar 24
Prospectus supplement for primary offering
4:06pm
, we are subject to reduced disclosure obligations regarding executive compensation arrangements in our periodic reports, proxy statements
424B5
bqo7zuont
19 Mar 24
Prospectus supplement for primary offering
5:18pm
PRE 14A
shuuocn9y0dhphiqitcj
18 Apr 23
Preliminary proxy
8:50am